RELATIONSHIP BETWEEN PARATHYROID HORMONE LEVEL AND HEPATIC STEATOSIS DEGREE BY FIBROSCAN AMONG PREVALENT HEMODIALYSIS PATIENTS | ||||
| Journal of the Egyptian Society of Parasitology | ||||
| Article 2, Volume 53, Issue 2, August 2023, Page 199-210 PDF (815.12 K) | ||||
| DOI: 10.21608/jesp.2023.312096 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| MAHA ABDELMONEIM BEHAIRY1; MAHMOUD ZAKI2; ABDELBASSET SHARAWY2; TAMER WAHID EL SAID1; RASHA SAMIR3 | ||||
| 1Department of internal medicine -Nephrology unite, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt | ||||
| 2Department of internal medicine -Nephrology unite,Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt | ||||
| 3Department of Internal Medicine- Gastroenterology and Hepatology unite, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt | ||||
| Abstract | ||||
| This study evaluated the hypothesis of a possible association between hyperparathyroidism and the presence of hepatic steatosis and fibrosis among prevalent hemodialysis (HD) patients and evaluated the possible risk factors of non-alcoholic fatty liver disease (NAFLD) among those patients. This is a case-control study that included HD patients divided into GI: (30) HD patients with NAFLD, GII: (25) HD patients without NAFLD as well as GIII: (30) healthy volunteers as a control. Viral hepatitis, Diabetes mellitus, recent hepatobiliary surgery, ascites, active infection, malignancy, alcohol, or drugs induce hepatic steatosis were excluded. Complete blood count, Iron profile, lipid profile, liver function tests, C- reactive protein (CRP) titer, intact parathyroid hormone (iPTH), and other routine chemistry tests were done. Transient elastography Fibroscan® to assess controlled attenuation parameter (CAP) to detect liver steatosis grades and liver stiffness measurement was done. Results: Mean ±SD values of CAP of liver steatosis (263.7±52.7, 181.3±23, 210.8±33.7) (dB/m) in GI, GII & control group respectively (P <0.001). Post-Hoc analysis revealed a significant statistical difference between G I and II as regards ALT, AST, Bilirubin level and serum albumin, CRP titer, and lipid profile. In HD patients' studied groups, the CAP value of liver steatosis was significantly correlated to BMI, ALT, AST, Cholesterol, LDL, TG, & CRP Titer, but not correlated to PTH or other parameters. In GIII, there was a significant correlation between the measured CAP value of liver steatosis and BMI, iPTH, CRP titer, ALT, AST, cholesterol, LDL, and a negative correlation between HDL and CAP value. Liver stiffness/ fibrosis was in 18 (60.0%), HD patients versus 8 (32%) patients in GII. Analysis showed a significant difference between GI & GII and between GI and GIII regarding the presence of liver fibrosis | ||||
| Keywords | ||||
| Hyperparathyroidism; Hepatic steatosis; Hemodialysis; NAFLD | ||||
|
Statistics Article View: 116 PDF Download: 126 |
||||
